A counteracting agent may be the stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, MW 1419, an anti-ulcer peptide per-orally active (12-15) that may also affect many central disturbances (16-23), efficient in inflammatory bowel disease trials (PL 14736) (24, 25) and various wound treatment (26-28), no toxicity reported (12, 13, 24, 25)) which showed various hepatoprotective effects (29-31)
Shelf Life: 24 months Declaration of Use: This product is intended for industrial use or scientific research only
In preclinical models , GLP-1 receptor activation has been shown to decrease fat mass and overall body weight
It's also a good choice when you want one peptide that can anchor a formula without making the ingredient list feel crowded
If you want to track your injections, you'll likely want to evaluate whether GLP BodyGuard covers that use case or whether you need a separate tool
PubMed Sinha R, et al